Azithromycin vs Ipilimumab

Azithromycin vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Azithromycin and Ipilimumab.

Mechanism of Action

Azithromycin: Binds 50S ribosomal subunit, inhibiting bacterial protein synthesis.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Azithromycin — 68 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Azithromycin — C38H72N2O12.

Molecular Weight: Azithromycin — 748.9840 g/mol.

Type: Azithromycin — Small molecule; Ipilimumab — Antibody.